University of Wisconsin
School of Medicine and Public Health

Cynthia Carlsson, MD, MS

PROFESSOR

GERIATRICS Faculty

WARF OFFICE BUILDING
610 WALNUT ST
MADISON, WI 53726-2336

(608) 256-1901

Education

  • University of Michigan Medical School, Ann Arbor, Michigan – MD
  • University of Wisconsin Hospital and Clinics/William S. Middleton Memorial Veterans Hospital – Residency in Internal Medicine
  • University of Wisconsin Hospital and Clinics/William S. Middleton Memorial Veterans Hospital – Fellowship in Geriatric Medicine
  • University of Wisconsin Hospital and Clinics/William S. Middleton Memorial Veterans Hospital – Fellowship in Older Women's Health
  • University of Wisconsin School of Medicine and Public Health – MS in Population Health Sciences

Professional Activities

Dr. Cynthia Carlsson is a faculty member of the Division of Geriatrics and Gerontology within the Department of Medicine. She is also the Louis A. Holland, Sr., Endowed Professor in Alzheimer’s Disease and the director of the Wisconsin Alzheimer's Institute; the Clinical Core leader and a co-leader for the Biomarker Core in the Wisconsin Alzheimer’s Disease Research Center; and a recipient of a University of Wisconsin Vilas Distinguished Achievement Professorship. Dr. Carlsson is a member of the National Institutes of Health/National Institute on Aging (NIH/NIA) Alzheimer’s Disease Centers Clinical Core Steering Committee and Clinical Task Force, and chairs several NIH/NIA research review committees.

Clinical Specialties

Dr. Carlsson is a geriatrician who treats veterans with dementia and memory issues at the William S. Middleton Memorial Veterans Hospital in Madison, Wisconsin, and is the co-director of the Memory Assessment Clinic there.

Research Interests

View Dr. Cynthia Carlsson's publications on NCBI My Bibliography

Dr. Carlsson's research focuses on the effects of vascular risk factors and their treatments on cognition and biomarkers for Alzheimer's disease in persons at risk for dementia. She and her colleagues are conducting clinical trials investigating the impact of vascular risk factors on risk of cognitive decline in middle-aged adults with parental history of Alzheimer's disease; how vascular risk factors are related to biomarkers for Alzheimer's disease found in the blood, cerebrospinal fluid (CSF), and on MRI scans measuring brain blood flow; the relationship between endothelial function and brain blood flow in persons at risk for Alzheimer's disease; and the effects of statins and fish oil on CSF biomarkers, brain blood flow, and cognition in asymptomatic middle-aged adults with parental history of Alzheimer's disease.